Litigation Details for Cipla Ltd. v. Sunovion Pharmaceuticals Inc. (D. Del. 2015)
✉ Email this page to a colleague
Cipla Ltd. v. Sunovion Pharmaceuticals Inc. (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-05-26 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 7,256,310 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Cipla Ltd. v. Sunovion Pharmaceuticals Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Cipla Ltd. v. Sunovion Pharmaceuticals Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-06-27 | 264 | appear in Sunovion's U.S. Patent No. 7,256,310 (the "'3W patent")-which is not asserted…history of its parent patent, U.S. Patent No. 6,995,286 (the '"286 patent"), and of other….S. Reissued Patent No. RE43,984 (the '"984 Reissue"). The asserted patent describes and…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 13 21 (internal quotation marks omitted). The patent specification | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
